PetDx is a molecular diagnostics company which is harnessing the power of genomics to develop a first-of-its-kind test for the detection, characterization, and management of canine cancer, based on a simple blood draw. Our cutting-edge approach to the science will radically change how we manage cancer in dogs, so they can enjoy longer, healthier lives with their humans.